ITMCTR2000003404已完成1 期
Therapeutic effect evaluation of Fu-Zheng Jie-Du Xiao-Ji approach in the treatment of hepatitis B virus-related hepatocellular carcinoma
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 性别
- All
入选标准
- •(1) the primary liver cancer diagnosis standard;
- •(2) Chronic hepatitis B virus infection;
- •(3) Male or female aged 18-65 years;
- •(4) Deficiency of qi and Yin and accumulation of poison and blood stasis;
- •(5) Sign the informed consent.
排除标准
- •(1) Liver cancer patients with metastasis from other tumors;
- •(2) Patients with other malignant tumors;
- •(3) Patients with serious heart and kidney complications or other primary diseases; Psychopaths;
- •(4) Upper gastrointestinal bleeding;
- •(5) Hepatorenal syndrome;
- •(6) Pregnant or lactating women;
- •(7) Patients cannot cooperate.
研究者
相似试验
尚未招募
1 期
Efficacy evaluation of Fuzheng Jiedu Xiaoji decoction in the treatment of Hepatitis B - related advanced liver cancer and key components researchiver CancerITMCTR2000002936Beijing Ditan Hospital, Capital Medical University
招募中
1 期
A clinical study on the efficacy of Xuefu Zhuyu Decoction in acute radiation esophagitis in esophageal cancer radiotherapyITMCTR2100004685Affiliated Hospital of Nanjing University of Chinese Medicine
招募中
1 期
A Clinical Study of the Efficacy of Fuzhenghuayu Granules Combined with Losartan in the Treatment of Primary GlomerulonephritisChronic glomerulonephritis (CKD3 stage)ITMCTR2000003765Shuguang Hospital affillated with Shanghai University of TCM
已完成
1 期
The therapeutic efficacy of Xuan-Fei Bai-Du decoction in the treatment of novel coronavirus pneumonia (COVID-19): a pilot randomized controlled trialovel Coronavirus Pneumonia (COVID-19)ITMCTR2000003500Wuhan Hospital of Traditional Chinese Medicine
已完成
不适用
Clinical efficacy evaluation of Jingxin Zhidong formula in the treatment of moderate and severe Tic DisorderITMCTR2100004402Guang'anmen Hospital of China Academy of Chinese Medical Sciences